Clinical Trial

CK0802 for Treatment of Steroid Refractory Graft vs. Host Disease (GVHD)

Name: CK0802 for Treatment of Steroid Refractory Graft vs. Host Disease (GVHD) — clinical trial record (NCT07576699)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting Phase 1/2

View on ClinicalTrials.gov →

Summary

The purpose of this study is to determine the efficacy and safety of CK0802 Tregs for treatment of refractory GVHD (graft-versus-host disease)

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2026-05-01.

Trial Details

NCT Number	NCT07576699
Lead Sponsor	Cellenkos, Inc.
Conditions	Steroid Refractory Graft Versus Host Disease
Enrollment	12 participants
Start Date	2026-07-01
Primary Completion	2028-06-30 (estimated)
Study Completion	2029-06-30 (estimated)
Updated on ClinicalTrials.gov	2026-05-11